MedTrace Logo

HLT transfemOral Replacement of aortIc Valve Via transcatherteriZatiON

NCT02157142 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2021-04-29

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and performance of the HLT System in patients with severe aortic stenosis who present at High Risk for aortic valve replacement surgery.

Conditions

  • Severe Aortic Stenosis
  • Aortic Valve Stenosis

Interventions

DEVICE

HLT Transcatheter Aortic Valve System

Transcatheter aortic valve replacement with an HLT Transcatheter Aortic Valve System

Sponsors & Collaborators

  • HLT Inc.

    lead INDUSTRY

Principal Investigators

  • Axel Linke, MD · University of Leipzig - Herzzcntrum

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2014-12-31
Completion
2019-10-31
FDA Device
Yes

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02157142 on ClinicalTrials.gov